EDGAR Filing Documents for 0001171843-14-003202

Form 8-K - Current report:

SEC Accession No. 0001171843-14-003202

Filing Date

2014-07-10

Accepted

2014-07-09 19:00:12

Documents

Period of Report

2014-07-09

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K FILING DOCUMENT	document.htm	8-K	6643
2	PRESS RELEASE	newsrelease.htm	EX-99	5873
	Complete submission text file	0001171843-14-003202.txt		13664

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 14968085
SIC: 2834 Pharmaceutical Preparations